Certificate of Analysis
Third Party Tested
Molecular Profile
Compound
BPC 157
Batch #
N/A
Formula
C62H98N16O22
Mol Wt
1419.5 g/mol
CAS
137525-51-0
Latest
ISO 17025
8× Testing
99.52%
Purity
VariantBPC 157
COA ##12723
Labeled20mg
Validation KeyAXISBIOTECH
Tested04/03/26
Full QC Panel - 8× tested
✓
Purity (HPLC) - 99.52%
✓
Net Peptide Content - 20mg
✓
Identity (HPLC) - BPC 157
✓
Fentanyl Screen - Not Detected
✓
HPLC Conformity mean - >99%
✓
ISO/IEC 17025 Accredited
Storage Requirements
Stability Information
Lyophilized (powder)
−20°C long-term
2–8°C
Reconstituted
Recommended condition
Light protection
Store away from light
Sealed lyophilized vials are heat-stable; refrigerating or freezing sealed vials is optional. 2–8°C applies to reconstituted solutions.
Peer-Reviewed Literature
Research & References
Research and reference material related to this compound.
01
Multifunctionality and Possible Medical Application of the BPC 157 Peptide — Literature and Patent Review
02
Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing
03
Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation
04
Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro
05
From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management
Safety & Regulatory Compliance Warning
These products are intended solely for laboratory research and analytical applications. They have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not approved for therapeutic use, diagnosis, treatment, or prevention of disease. Under no circumstances should these materials be used for human or animal consumption.
